Synaptic
Deal Sourcing & Portfolio Management tools for Private Investors
130 employees · est. 2016 · San Francisco, United States
Syndesi Therapeutics
Syndesi Therapeutics is developing a drug for consecutive cognitive disorders using exclusive technology from UCB.
2-10 employees · est. 2018 · United States
Synaptic is the older company (2016 vs 2018); Synaptic is the larger of the two.
Side-by-Side Comparison
| Metric | Synaptic | Syndesi Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2018 |
| Headquarters | ||
| Headquarters | San Francisco, United States | United States |
| Employees | ||
| Employees | 130 larger | 2-10 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series B | Series A |
| Total Funding | ||
| Total Funding | $20.00M | $26.20M |
| Funding Rounds | ||
| Funding Rounds | 1 | 3 |
| Services | ||
| Services | Startup discovery, Investment analysis, Growth signal monitoring, Founder and team insights, Portfolio IQ | Not tracked yet |
| Target Customers | ||
| Target Customers | Venture capital firms, Angel investors, Private equity investors, Investment analysts, Growth funds | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Data Intelligence, Alternative Data, Deal Sourcing, Portfolio Management, Venture Capital, Private Equity, Hedge Funds, No-Code Platform, Company Insights, Analytics Toolkit, Due Diligence, Investment Process, Research Workflow, Custom Data Integration, Sector Analysis | Biopharmaceuticals, Cognitive Disorders, Neurological Conditions, Drug Development, SV2A, Synaptic Vesicle Protein, Neuroscience, Exclusive Technology, UCB, Platform Technology, Molecules, Synaptic Transmission, Neurons |
| Website | ||
| Website | synaptic.com | syndesitherapeutics.com |
About Synaptic
Synaptic, founded in 2016, is a prominent player in the realm of data intelligence platforms tailored for private investors. The company supports crucial stages of the investment process, from deal sourcing to portfolio management, positioning itself as an indispensable tool for top-tier investors....
About Syndesi Therapeutics
Syndesi Therapeutics is a biotech startup founded in 2018 and based in the United States. The company's focus is on developing a drug candidate for cognitive disorders associated with various neurological conditions. It holds an exclusive license to its platform technology from UCB, a prominent rese...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Synaptic and Syndesi Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Synaptic and Syndesi Therapeutics — by email.
Frequently Asked Questions
Compare Synaptic with someone else
Start typing a company name or domain.